Targeting pancreatic cancer using a combination of gemcitabine with the omega‐3 polyunsaturated fatty acid emulsion, Lipidem<b>™</b>

Abstract

Lipidem™ in combination with gemcitabine, has anti-proliferative and anti-invasive efficacy in vitro, with pancreatic stellate cells exhibiting the greatest sensitivity to this combination.